Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific double-strand breaks (DSBs) at desired locations in the genome. The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in targeted mutations.
The increasing application of genome engineering in treating chronic ailments and therapeutics will be one of the key factors fueling the growth of genome editing market during the next few years. With the continuous prevalence of infectious and chronic diseases such as hepatitis, tuberculosis, malaria, HIV/AIDS, and others, the application of genome editing in treating these ailments has increased considerably in the recent years. According to CDC, there were about 1.8 million new cases of HIV reported in 2016. Such a rapidly increasing number of HIV cases have led to the researchers to work on new gene-based therapies for reducing morbidity and mortality of HIV-infected patients. Consequently, the rise in prevalence of such ailments will impact the demand for novel therapies equipping several genome editing tools in the forthcoming years.

Market Analysis and Insights: Global Genome Editing Market
The global Genome Editing market size is projected to reach US$ 6739.8 million by 2027, from US$ 3513 million in 2020, at a CAGR of 9.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genome Editing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genome Editing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genome Editing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genome Editing market.

Global Genome Editing Scope and Market Size
Genome Editing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genome Editing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CRISPR
TALEN
ZFN

Segment by Application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Genscript
Horizon Discovery Group
Lonza
Merck KGaA
Sangamo Therapeutics
Thermo Fisher Scientific